Using live, attenuated influenza vaccine for prevention and control of influenza; supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP)

Bridges, Carolyn B.; Cox, Nancy (Nancy J.); Fukuda, Keiji; Harper, Scott A.

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Using live, attenuated influenza vaccine for prevention and control of influenza; supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP)

Published Date:

September 26, 2003

Status:

superseded

| This document has been replaced by: Prevention and control of seasonal influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 influenza season

[PDF-256.79 KB]

Details:

Personal Authors:

Bridges, Carolyn B. ; Cox, Nancy (Nancy J.) ; Fukuda, Keiji ; Harper, Scott A. ;

Corporate Authors:

United States, Advisory Committee on Immunization Practices. ; National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases. ; National Immunization Program (Centers for Disease Control and Prevention), Epidemiology and Surveillance Division.

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 52, no. RR-13

Keywords:

[+]

Pubmed ID:

14557799

Description:

This report summarizes recommendations by the Advisory Committee on Immunization Practices (ACIP) for using intranasally administered, trivalent, cold-adapted, live, attenuated influenza vaccine (LAIV), which was approved for use in the United States on June 17, 2003 (FluMist trade mark, produced by MedImmune, Inc., Gaithersburg, Maryland). LAIV is currently approved for use among healthy persons (i.e., those not at high risk for complications from influenza infection) aged 5-49 years. This report includes information regarding 1) vaccine composition and mechanisms of action; 2) comparison between LAIV and trivalent inactivated influenza vaccine; 3) effectiveness and safety of LAIV; 4) transmission and stability of LAIV viruses; 5) recommendations and contraindications for using LAIV; and 6) dosage and administration of LAIV. This report supplements the 2003 ACIP recommendations regarding prevention and control of influenza (CDC. Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2003;52[No. RR-8]:1-36.)

Document Type:

Journal Issue

Collection(s):

Stephen B. Thacker CDC Library collection
Guidelines and Recommendations

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

Guidelines for vaccinating dialysis patients and patients with chronic kidney disease; summarized from recommendations of the Advisory Committee on Immunization Practices (ACIP)

Personal Author:

Chi, Carolyn; Moore, Matt; Murphy, Trudy V.; Patel, Priti R.; Pilishvili, Tamara; Strikas, Raymond A.;

Corporate Author:

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.);

Published:

December 2012

Description:

This summary is not meant to apply to chronic kidney disease patients who are recently post-transplant. These patients are considered more significantly immunosuppressed than those who have only chronic kidney disease, with or without dialysis. Deter...

Status:

current

File Type:

[PDF - 833.32 KB]
General best practice guidelines for immunization : best practices guidance of the Advisory Committee on Immunization Practices (ACIP)

Personal Author:

Kroger, Andrew T.; Duchin, Jeffrey S.; Vázquez, Marietta;

Corporate Author:

United States, Advisory Committee on Immunization Practices.; National Center for Immunization and Respiratory Diseases (U.S.);

Published:

4/20/17

Description:

The Centers for Disease Control and Prevention (CDC) recommends routine vaccination to prevent 17 vaccine-preventable diseases that occur in infants, children, adolescents, or adults. This report provides information for clinicians and other health c...

File Type:

[PDF - 1.16 MB]
Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine

Personal Author:

Chung, Jessie R.; Flannery, Brendan; Thompson, Mark G.; Gaglani, Manjusha; Jackson, Michael L.; Monto, Arnold S.; Nowalk, Mary Patricia; Talbot, H. Keipp; Treanor, John J.; Belongia, Edward A.; Murthy, Kempapura; Jackson, Lisa A.; Petrie, Joshua G.; Zimmerman, Richard K.; Griffin, Marie R.; McLean, Huong Q.; Fry, Alicia M.;

Published:

Jan 05 2016

Source:

Pediatrics. 137(2):1-10.

Description:

BACKGROUND : Few observational studies have evaluated the relative effectiveness of live attenuated (LAIV) and inactivated (IIV) influenza vaccines against medically attended laboratory-confirmed influenza. : METHODS : We analyzed US Influenza Vaccin...

File Type:

[PDF - 340.98 KB]
Influenza vaccination of health-care personnel; recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP)

Personal Author:

Pearson, Michele L.; Bridges, Carolyn B.; Harper, Scott A.;

Corporate Author:

Hospital Infection Control Practices Advisory Committee (U.S.); Centers for Disease Control and Prevention (U.S.); United States. Advisory Committee on Immunization Practices;

Published:

February 24, 2006

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 55, no. RR-2

Description:

"This report summarizes recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP) concerning influenza vaccination of health-care personnel (HCP) in the Unite...

Status:

current

File Type:

[PDF - 625.70 KB]
Guidelines for vaccinating pregnant women; abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP)

Corporate Author:

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.);

Published:

March 2013

Description:

The table on the following page may be used to find the general rule for vaccinating a pregnant woman with a particular vaccine. The third column of the table refers the reader to the page in this document where more specific information from the app...

File Type:

[PDF - 1.46 MB]